drugset / Trial / NCT00005638

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

NCT00005638 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy plus radiation therapy in treating patients who have advanced cancer of the esophagus.

Timeline

Start
1999-10
Primary completion
2004-04
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 40 mg/m2 Intravenous
Subject Irinotecan Small molecule 50 mg/m2 Intravenous
Subject Irinotecan Small molecule 65 mg/m2 Intravenous
Subject Irinotecan Small molecule 80 mg/m2 Intravenous
Background Cisplatin Other / unclassified 30 mg/m2 Intravenous